On July 29, 2020 Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer reported that it will release its second quarter financial results on Thursday, August 5, 2020 after the market closes (Press release, Kezar Life Sciences, JUL 29, 2020, View Source [SID1234562527]). Kezar’s executive team will host a conference call to discuss the company’s second quarter 2020 financial results and provide a general business update.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The conference call and webcast is scheduled for August 5, 2020 at 4:30 PM EDT. In order to participate in the conference call, please dial +1- 877-407-9711 (U.S.Toll-Free). An audio webcast and international dial-in numbers can be accessed under "News/Events" through the "Investors" section of the Kezar corporate website at www.kezarlifesciences.com. Kezar Life Sciences will maintain an archived replay of the webcast on its website for 90 days.